Pharmaceutical Effluent Testing is required by 40 CFR 439 for those engaged in discharging waste water containing potential pharmaceutical contaminants. Teklab, Inc is a NELAC accredited environmental testing laboratory that provides specialty analysis such as those required for pharmaceutical manufacturing industry (PMI) wastewater effluent or groundwater monitoring. EPA 524.2 includes the following compounds:

• 1,2-Dichlorobenzene
• 1,2-Dichlorobenzene-d4
• 1,2-Dichloroethane
• Amyl 4-Bromofluorobenzene
• Acetone
• Benzene
• Chlorobenzene
• Chloroform
• Methylene chloride
• Tetrahydrofuran
• Toluene

Our volatile organics department routinely performs specialty analysis like EPA 524.2 PMI for other environmental testing labs. Teklab also analyses PMI compounds by Methods EPA 1666 and EPA1671.

If you have any questions please feel free to email us:

Rich Mannz (Teklab Senior Sales Executive)

Kelly Klostermann (Teklab Sales Executive)

General contact information can be found here

We realize that there are a lot of unique organic compounds in existence and local regulatory agencies may require testing for compounds that are not on the standard EPA or SW846 lists. When those situations arise, we can (and do) perform validation studies to see if your particular compound can be extracted and analyzed using those reference methods and thus meet NELAP accreditation standards.

We recommend that you contact a NELAP accredited Environmental Testing Laboratory even if your organic compound of concern is not “routinely” analyzed or in an EPA approved testing method.

• Permit Guidance Document: Pharmaceutical Manufacturing Point Source Category (40CFR Part439) January 2009
• EPA Guidelines: Analytical Method Guidance for the Pharmaceutical Manufacturing Point Source Category. August 1999
• Federal Register (Sep 21st 1998). 40CFR Parts 136 and 439. Pharmaceutical Manufacturing Category. Effluent Limitations Guidelines, Pretreatment Standards and New Source Performance Standards; Final Rule